Lantern Pharma Inc.

3.71
-0.24 (-6.08%)
At close: Mar 03, 2025, 3:59 PM
3.55
-4.37%
After-hours: Mar 03, 2025, 05:46 PM EST

Lantern Pharma Balance Sheet Statement

Year FY23 FY22 FY21 FY20 FY19 FY18
Cash & Equivalents 21.94M 37.2M 51.52M 19.23M 1.23M 445.16K
Short-Term Investments 19.36M 17.99M 19.2M n/a n/a n/a
Long-Term Investments n/a n/a 1M n/a n/a n/a
Other Long-Term Assets 25.87K 17.89K 17.89K 101.2K 191K n/a
Receivables n/a n/a n/a n/a n/a n/a
Inventory n/a -592K -181K n/a n/a n/a
Other Current Assets 2.47M 3.53M 1.03M 806K 788.00 n/a
Total Current Assets 43.34M 58.72M 72.72M 20.24M 1.23M 445.16K
Property-Plant & Equipment 280.42K 95.69K 216.19K 21.51K 8.76K 4.67K
Goodwill & Intangibles n/a n/a n/a n/a n/a n/a
Total Long-Term Assets 306.29K 113.58K 1.23M 122.71K 199.76K 4.67K
Total Assets 43.65M 58.84M 73.95M 20.36M 1.43M 449.83K
Account Payables n/a 932.41K 681.11K 432.34K 478.29K 97.63K
Deferred Revenue n/a -2.75M -2.17M n/a n/a n/a
Short-Term Debt 172.97K 52.89K 152.06K n/a n/a n/a
Other Current Liabilities 2.51M 1.81M 1.49M 120K 11K 554K
Total Current Liabilities 2.68M 2.8M 2.33M 552.34K 489.29K 651.63K
Long-Term Debt 61.5K n/a 52.89K 108.5K n/a n/a
Other Long-Term Liabilities n/a n/a n/a n/a n/a n/a
Total Long-Term Liabilities 61.5K 52.89K 52.89K 108.5K n/a n/a
Total Liabilities 2.74M 2.8M 2.38M 660.84K 489.29K 651.63K
Total Debt 234.47K 52.89K 204.95K 108.5K n/a n/a
Common Stock 1.07K 1.09K 1.11K 622.00 11.37K 11.37K
Retained Earnings -55.24M -39.28M -25.02M -12.66M -6.75M -4.32M
Comprehensive Income -107.46K -371.39K -92.69K -0.00 n/a n/a
Shareholders Equity 40.91M 56.04M 71.57M 19.7M 943.28K -201.8K
Total Investments 19.36M 17.99M 19.2M n/a n/a n/a